Mutation scanning using MUT-MAP, a high-throughput, microfluidic chip-based, multi-analyte panel.

Mutation scanning using MUT-MAP, a high-throughput, microfluidic chip-based, multi-analyte panel.

Targeted anticancer therapies rely on the identification of patient subgroups most likely to respond to treatment. Predictive biomarkers play a key role in patient selection, while diagnostic and prognostic biomarkers expand our understanding of tumor biology, suggest treatment combinations, and fac...

Full description

Bibliographic Details
Main Authors: Rajesh Patel, Alison Tsan, Rachel Tam, Rupal Desai, Jill Spoerke, Nancy Schoenbrunner, Thomas W Myers, Keith Bauer, Edward Smith, Rajiv Raja
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23284662/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23284662/?tool=EBI

Similar Items